Elmiron lawsuits are being filed by patients who have experienced eye problems due to Elmiron, which is a bladder disease treatment medicine. In recent years there have been reports of patients who used Elmiron developing vision loss due to Elmiron-related maculopathy. But there were not any warnings about these Elmiron eye problems in the Elmiron Prescribing Information document, or drug label, until June 2020.
Remarkably, prior to that time, despite reports of Elmiron-related maculopathy, the Prescribing Information for Elmiron in the US simply stated “Warnings: None”.
The June 2020 Elmiron label change which finally added warnings concerning vision problems such as retinal pigmentary changes and pigmentary maculopathy was overdue from our perspective. Accordingly, there have been Elmiron lawsuits filed by patients who have eye problems due to Elmiron against the pharmaceutical companies responsible for Elmiron.
The growing number of Elmiron lawsuits filed by patients usually contain these types of legal claims alleged against the drug companies: Strict Liability / Negligence / Misrepresentation / Breach of Warranty.
We are currently investigating possible Elmiron lawsuits for patients who have been diagnosed with eye problems due to Elmiron, such as retinal maculopathy, pigmentary maculopathy, and macular degeneration.
It is important for patients who used Elmiron to know that maculopathy — which is a degeneration of the central part of the retina — can have a range of symptoms, including:
• Central vision loss
• Blurred, dimmed, or spotty vision
• Difficulty reading
• Difficulty adjusting to low light or changes in lighting
• Pain in the eye
Significantly, a person does not need to be using Elmiron up until the time when their Elmiron-related eye problem was diagnosed to be in a position to file an Elmiron lawsuit (unlike most other drug injury cases).
Please feel free to contact us if we can be of assistance as regards a possible Elmiron lawsuit.
[View article at original source]